Active ingredientDigitoxinCat. No. P-D116-001CAS 71-63-6Family · Pharmaceutical analytical standards
Digitoxin
A cardiac glycoside obtained from the purple foxglove (Digitalis purpurea), first prepared in pure form in 1875 by Oswald Schmiedeberg; it is used in heart failure, especially in people with impaired kidney function, and in some arrhythmias such as atrial fibrillation. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It stays in the body for a very long time: its half-life is 7 to 8 days. As early as 1785, English physician William Withering had described the plant's medical uses in his famous treatise on the foxglove.
Go to the active ingredient →Active ingredientDigitoxinCat. No. P-D116-001CAS 71-63-6
Isotopically labelledDigitoxin-d3Cat. No. P-D116-002
ImpurityDigitalinCat. No. P-D116-003CAS 752-61-4
ImpurityDigitoxigeninCat. No. P-D116-004CAS 143-62-4
ImpurityDigitoxin 3'''-AcetateCat. No. P-D116-005CAS 1111-39-3
ImpurityGitoxigeninCat. No. P-D116-006CAS 545-26-6
ImpurityGitoxinCat. No. P-D116-007CAS 4562-36-1No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceDigitoxin CRSEDQM code D1800000Family DigitoxinReference substanceDigitoxin for LC assay CRSEDQM code Y0002036Family DigitoxinReference substanceGitoxin CRSEDQM code G0300000Family DigitoxinNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.